Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of HIP2101 in Healthy Volunteers
NCT04967014Phase 1Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of esomeprazole in gastritis (2 arms), sponsored by Hanmi Pharmaceutical. Primary endpoint: Duration time with integrated gastric pH > 4. Started May 2021; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT04967014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04967014.